Oyler John

Chief Executive Officer

1 company

Good

Trades Analyzed

12M Win Rate

54.3%

Avg 3M Return

-7.3%

Avg 12M Return

+5.4%

Oyler John is a Chief Executive Officer at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 197 sells.

Estimated insider holdings value: $2.4M based on current market prices.

Holdings by Company

ONCDec 16, 2025

Current Shares8.7K

Value$2.35M

Net Activity-2,285,189

Bought: 0Sold: 2.29M

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 2, 2021	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	288,639	$109.77	$31,685,323.75	-2.7%	+5.7%	-49.9%
Aug 5, 2021	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	110,860	$105.11	$11,652,049.45	-1.3%	+11.3%	-42.1%
Aug 3, 2021	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	83,359	$182.37	$15,202,048.13	-1.5%	+4.7%	-50.3%
Jul 22, 2021	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	69,216	$71.82	$4,971,360.27	-1.2%	+15.8%	-43.9%
Jul 21, 2021	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	76,040	$163.22	$12,410,908.16	-0.7%	+22.6%	-38.5%
Jul 8, 2021	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	67,481	$94.83	$6,399,303.10	-1.1%	+5.9%	-41.0%
Jul 7, 2021	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	123,821	$117.22	$14,514,636.75	-0.9%	+10.2%	-39.3%
Sep 29, 2020	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	54,303	$280.39	$15,226,093.35	-22.1%	-	-
Sep 16, 2020	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	81,228	$253.46	$20,587,969.07	-34.2%	-	-
Sep 2, 2020	ONC Beone Medicines Ltd.	Chief Executive Officer	Sell	61,042	$233.21	$14,235,597.46	-23.4%	-	-